Molecular structure of Irinotecan Carboxylate Sodium Salt
Irinotecan Carboxylate Sodium Salt
Alternate Names:
(αS)-2-[([1,4-Bipiperidin]-1-ylcarbonyl)oxy]-α,12-diethyl-9,11-dihydro-α-hydroxy-8-(hydroxymethyl)-9-oxo-indolizino[1,2-b]quinoline-7-acetic Acid Sodium Salt; CPT 11 Carboxylic Acid Sodium Salt
Application:
Irinotecan Carboxylate Sodium Salt is a carboxylated Topo I inhibitor
Molecular Weight:
626.68
Molecular Formula:
C33H39NaN4O7
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Carboxylate form of Irinotecan,
Irinotecan Carboxylate Sodium Salt References
Kunimoto, T., et al.: Cancer Res., 47, 5944 (1987) Shimada, Y., et al.: J. Clin. Oncol., 11, 909 (1993) Chen, A., et al.: Annu. Rev. Pharmacol. Toxicol., 34, 191 (1994)Inhibitor of:
Topo I.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Irinotecan Carboxylate Sodium Salt, 5 mg | sc-280848 | 5 mg | $360.00 |